AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS
Yıl: 2022 Cilt: 33 Sayı: 2 Sayfa Aralığı: 50 - 56 Metin Dili: İngilizce DOI: 10.4274/jtss.galenos.2022.35744 İndeks Tarihi: 25-06-2022
AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS
Öz: Objective: Amifostine is a known radioprotective agent. It has been known for many years that it protects normal tissue from the undesirable
effects of radiation and some chemotherapeutics due to its antioxidant effect and contains thiol. We investigated the effects of amifostine
on the activity of lipid peroxidation in the spinal cord after experimental spinal cord injury in rats.
Materials and Methods: Thirty-five male Wistar albino rats were randomly divided into five groups, each containing seven rats. Group I (the
control group) received laminectomies and spinal cord samples were obtained 24 h after laminectomy without trauma. Those in groups II to V
all received laminectomies followed by traumatic spinal cord injury and tissue samples were taken 24 h later. Group II received no treatment;
group III received 30 mg/kg methylprednisolone; group IV received 200 mg/kg amifostine; and group V received 2 mL 0.9% sodium chloride
(sulfur tetrafluoride) solution. Medications were given intraperitoneally as single doses immediately after trauma. Spinal cord samples were
taken 24 h post-trauma and studied for lipid peroxidation activity.
Results: Lipid peroxidation activity in the tissue samples was increased by injury. Both amifostine and methylprednisolone treatment
decreased this activity, indicating a reduction in neutrophil infiltration of the damaged tissue. The effect of amifostine on lipid peroxidation
activity was similar to that of methylprednisolone.
Conclusion: Amifostine may be effective in protecting the spinal cord from secondary injury.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Ahmad M, Zakaria A, Almutairi KM. Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats. Pharmacol Biochem Behav. 2016;145:45-54.
- 2. Aslan A, Cemek M, Buyukokuroglu ME, Altunbas K, Bas O, Yurumez Y, et al. Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J. 2009;18:1442-51.
- 3. Allen AR. Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J Nerv Dis. 1914;41:141-7.
- 4. Kuropatnicki AK, Szliszka E, Kłósek M, Król W. The beginnings of modern research on propolis in poland. Evid Based Complement Alternat Med. 2013;2013:983974.
- 5. Rogers WK, Todd M. Acute spinal cord injury. Best Pract Res Clin Anaesthesiol. 2016;30:27-39.
- 6. Zhang N, Yin Y, Xu SJ, Wu YP, Chen WS. Inflammation & apoptosis in spinal cord injury. Indian J Med Res. 2012;135:287-96.
- 7. Teke Z, Bostanci EB, Yenisey C, Sacar M, Simsek NG, Akoglu M. Caffeic acid phenethyl ester alleviates mesenteric ischemia/reperfusion injury. J Invest Surg. 2012;25:354-65.
- 8. Anjum A, Yazid MD, Fauzi Daud M, Idris J, Ng AMH, Selvi Naicker A, et al. Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. Int J Mol Sci. 2020;21:7533.
- 9. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41:1819-28.
- 10. Keane RW, Kraydieh S, Lotocki G, Bethea JR, Krajewski S, Reed JC, et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol. 2001;60:422-9.
- 11. Kazanci A, Seckin H, Karadeniz U, Kazanci D, Turan S, Kazanci B, et al. Comparison of the effect of mexiletine and methylprednisolone on neural function and histopathological damage after transient spinal cord ischemia in rabbits. Turk Neurosurg. 2010;20:43-9.
- 12. Karatas Y, Cengiz SL, Esen H, Toker A, Savas C. Effect of Carvedilol on Secondary Damage in Experimental Spinal Cord Injury in Rats. Turk Neurosurg. 2015;25:930-5.
- 13. Akdağ R, Uçkun ÖM, Dalgiç A, Take G. Consumptıon of green tea or ıts derıvatıve catechın may ımprove neural regeneratıon ın a rat spınal cord ınjury model. J Turk Spinal Surg. 2020;31:170-5.
- 14. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2012;1:CD001046.
- 15. Evaniew N, Belley-Côté EP, Fallah N, Noonan VK, Rivers CS, Dvorak MF. Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis. J Neurotrauma. 2016;33:468-81.
- 16. Peters GJ, van der Vijgh WJ. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR2721): preclinical aspects. Eur J Cancer. 1995;31A Suppl 1:S1-7.
- 17. Capizzi RL. Clinical status and optimal use of amifostine. Oncology (Williston Park). 1999;13:47-59; discussion 63, 67.
- 18. Kalaycioglu M, Bukowski R. Clinical status of the new cytoprotective agent, amifostine. Oncology (Williston Park). 1994;8:15-6, 19-20.
- 19. Capizzi R. Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin Oncol. 1996;23(4 Suppl 8):2-17.
- 20. List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL. Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity. Semin Oncol. 1996;23(4 Suppl 8):58-63.
- 21. Alberts DS. Protection by amifostine of cyclophosphamide-induced myelosuppression. Semin Oncol. 1999;26(2 Suppl 7):37-40.
- 22. Christie SD, Comeau B, Myers T, Sadi D, Purdy M, Mendez I. Duration of lipid peroxidation after acute spinal cord injury in rats and the effect of methylprednisolone. Neurosurg Focus. 2008;25(5):E5.
- 23. Diaz-Ruiz A, Rios C, Duarte I, Correa D, Guizar-Sahagun G, Grijalva I, et al. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuroreport. 2000;11:1765-7.
- 24. Gocmez C, Celik F, Kamasak K, Kaplan M, Uzar E, Arıkanoglu A, et al. Effects of intrathecal caffeic acid phenethyl ester and methylprednisolone on oxidant/antioxidant status in traumatic spinal cord injuries. J Neurol Surg A Cent Eur Neurosurg. 2015;76:20-4.
- 25. Taoka Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol. 1998;56:341-58.
- 26. Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8:152-67.
- 27. Katoh H, Yokota K, Fehlings MG. Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds. Front Cell Neurosci. 2019;13:248.
- 28. Dimitrijevic MR, Danner SM, Mayr W. Neurocontrol of Movement in Humans With Spinal Cord Injury. Artif Organs. 2015;39:823-33.
- 29. Dogan G, Karaca O. N-methyl-D-aspartate Receptor Antagonists may Ameliorate Spinal Cord Injury by Inhibiting Oxidative Stress: An Experimental Study in Rats. Turk Neurosurg. 2020;30:60-8.
- 30. Kahveci FO, Kahveci R, Gokce EC, Gokce A, Kısa Ü, Sargon MF, et al. Biochemical, pathological and ultrastructural investigation of whether lamotrigine has neuroprotective efficacy against spinal cord ischemia reperfusion injury. Injury. 2021;52:2803-12.
- 31. Ishii H, Petrenko AB, Sasaki M, Satoh Y, Kamiya Y, Tobita T, et al. Free radical scavenger edaravone produces robust neuroprotection in a rat model of spinal cord injury. Brain Res. 2018;1682:24-35.
- 32. Chio JCT, Wang J, Badner A, Hong J, Surendran V, Fehlings MG. The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit. J Neuroinflammation. 2019;16:141.
- 33. Sámano C, Nistri A. Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone. Neurochem Res. 2019;44:200-13.
- 34. Nieder C, Andratschke NH, Wiedenmann N, Molls M. Prevention of radiation-induced central nervous system toxicity: a role for amifostine? Anticancer Res. 2004;24:3803-9.
- 35. Giannopoulou E, Katsoris P, Parthymou A, Kardamakis D, Papadimitriou E. Amifostine protects blood vessels from the effects of ionizing radiation. Anticancer Res. 2002;22:2821-6.
- 36. Kruse JJ, Strootman EG, Wondergem J. Effects of amifostine on radiation-induced cardiac damage. Acta Oncol. 2003;42:4-9.
- 37. Lamproglou I, Djazouli K, Boisserie G, Patin PH, Mazeron JJ, Baillet F. Radiation-induced cognitive dysfunction: the protective effect of ethyol in young rats. Int J Radiat Oncol Biol Phys. 2003;57:1109-15.
- 38. Spence AM, Krohn KA, Edmondson SW, Steele JE, Rasey JS. Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection. Int J Radiat Oncol Biol Phys. 1986;12:1479-82.
- 39. Ang KK, van der Kogel AJ, Van Dam J, van der Schueren E. The kinetics of repair of sublethal damage in the rat cervical spinal cord during fractionated irradiations. Radiother Oncol. 1984;1:247-53.
| APA | güler a, Okutan M (2022). AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. , 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| Chicago | güler ali,Okutan Mehmet Özerk AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. (2022): 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| MLA | güler ali,Okutan Mehmet Özerk AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. , 2022, ss.50 - 56. 10.4274/jtss.galenos.2022.35744 |
| AMA | güler a,Okutan M AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. . 2022; 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| Vancouver | güler a,Okutan M AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. . 2022; 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| IEEE | güler a,Okutan M "AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS." , ss.50 - 56, 2022. 10.4274/jtss.galenos.2022.35744 |
| ISNAD | güler, ali - Okutan, Mehmet Özerk. "AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS". (2022), 50-56. https://doi.org/10.4274/jtss.galenos.2022.35744 |
| APA | güler a, Okutan M (2022). AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. Journal of Turkish Spinal Surgery, 33(2), 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| Chicago | güler ali,Okutan Mehmet Özerk AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. Journal of Turkish Spinal Surgery 33, no.2 (2022): 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| MLA | güler ali,Okutan Mehmet Özerk AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. Journal of Turkish Spinal Surgery, vol.33, no.2, 2022, ss.50 - 56. 10.4274/jtss.galenos.2022.35744 |
| AMA | güler a,Okutan M AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. Journal of Turkish Spinal Surgery. 2022; 33(2): 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| Vancouver | güler a,Okutan M AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS. Journal of Turkish Spinal Surgery. 2022; 33(2): 50 - 56. 10.4274/jtss.galenos.2022.35744 |
| IEEE | güler a,Okutan M "AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS." Journal of Turkish Spinal Surgery, 33, ss.50 - 56, 2022. 10.4274/jtss.galenos.2022.35744 |
| ISNAD | güler, ali - Okutan, Mehmet Özerk. "AMIFOSTINE DECREASES LIPID PEROXIDATION ACTIVITY AFTER SPINAL CORD INJURY IN RATS". Journal of Turkish Spinal Surgery 33/2 (2022), 50-56. https://doi.org/10.4274/jtss.galenos.2022.35744 |
